Approval based on FLAURA2 results, which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly nine months compared to standard of care MISSISSAUGA, ON – Health Canada has granted… Read More
A renowned third-party sterilization service provider in Japan, medical bear, has forged a strategic partnership with Getinge in a transformation program focusing on digitalization of the company’s sterile supply flow…. Read More
NM26 is a Phase 2-ready, first-in-class bispecific antibody targeting two clinically proven pathways in atopic dermatitis (AD) The Company is leveraging a multi-pathway approach to transform treatment in atopic dermatitis… Read More
Collaboration to improve access to testing services and the delivery of timely results for patients BURLINGTON, NC — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into… Read More
RESEARCH TRIANGLE PARK, NC – IQVIA™ (NYSE:IQV) announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs… Read More
